December 4, 2018
We conducted successful testing and run-through of the study protocol for our novel technology RESPINOR DXT with our principal investigator from Paris, Alexandre Demoule. This feasibility study will commence early in the New Year.
-
Product • Newsroom • Team • Board of Directors • Investors • About • Contact • Privacy Policy • Instructions For Use
RESPINOR: MedTech innovator specializing in diaphragm monitoring, introducing DXT, a non-invasive ultrasound-based technology to improve critical care and outcomes.
ReSPINOR AS
Address: Gaustadalleen 21, 0349 Oslo, Norway
Phone: +47 24 02 25 54
Mail: mail@respinor.com
Monday-Friday: 8:30 to 17:00